NewAmsterdam Pharma Announces Initial Data from Phase 2a Clinical Trial Evaluating Obicetrapib in Patients with Early Alzheimer’s Disease Who Carry an ApoE4 Mutation
— Observed reductions of 11% and 12% in 24- and 27-hydroxycholesterol in cerebrospinal fluid (“CSF”),…
Hour9 Launches AI Automation Agency with Process-First Approach, Challenging Assumption That Businesses Should Maximize AI Integration
Sixty-Six Capital Expands Effective Bitcoin Exposure with Option for up to 200 BTC and Move to Direct Holdings
NTG Clarity to Announce Second Quarter Financial Results on August 27, 2026 with Earnings Call to Follow
SonicStrategy Reports Q2 2026 Staking Revenue and Reduced Monthly Burn
QSE Closes Second Tranche of Private Placement of $6 Million